Cargando…
Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy
BACKGROUND: Early highly active antiretroviral therapy (HAART), started within the first months of age, has been proven to be the optimal strategy to prevent immunological and clinical deterioration in perinatally HIV-infected children. Nevertheless, data about long-term follow-up of early treated c...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753343/ https://www.ncbi.nlm.nih.gov/pubmed/19709432 http://dx.doi.org/10.1186/1471-2334-9-140 |